Low‐dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor‐titer below 200 BU/mL

ABSTRACT Importance It remained unclear that the efficacy comparison between low‐dose immune tolerance induction (LD‐ITI) incorporating immunosuppressants (IS) when severe hemophilia A (SHA) patients had inhibitor‐titer ≥200 Bethesda Units (BU)/mL (LD‐ITI‐IS200 regimen) and LD‐ITI combining with IS...

Полное описание

Библиографические подробности

Главные авторы:	Zhengping Li, Jie Sun, Zekun Li, Zhenping Chen, Guoqing Liu, Wanru Yao, Xiaoling Cheng, Gang Li, Yingzi Zhen, Di Ai, Yaohan Zhou, Qianqian Mao, Man‐Chiu Poon, Runhui Wu
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wiley 2024-06-01
Серии:	Pediatric Investigation
Предметы:	Hemophilia A High‐titer inhibitor Immune tolerance induction Immunosuppressant Low‐dose
Online-ссылка:	https://doi.org/10.1002/ped4.12429
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!